The DOI matches its Crossref record; 925 of the 925 references it cites were found in a registry or an index.
Targeting Metalloenzymes for Therapeutic Intervention
Open accessAbstract
Metalloenzymes are central to a wide range of essential biological activities, including nucleic acid modification, protein degradation, and many others. The role of metalloenzymes in these processes also makes them central for the progression of many diseases and, as such, makes metalloenzymes attractive targets for therapeutic intervention. Increasing awareness of the role metalloenzymes play in disease and their importance as a class of targets has amplified interest in the development of new strategies to develop inhibitors and ultimately useful drugs. In this Review, we provide a broad overview of several drug discovery efforts focused on metalloenzymes and attempt to map out the current landscape of high-value metalloenzyme targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 925
Polyubiquitin Binding and Disassembly By Deubiquitinating Enzymes
Reyes‐Turcu, F. E., & Wilkinson, K. D. (2009) · Chemical Reviews · doi:10.1021/cr800470j · Cited by 156
Torphy, T. J., Barnette, M. S., Underwood, D. C., Griswold, D. E., Christensen, S. B., Murdoch, R. D., Nieman, R. B., & Compton, C. H. (1999) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.1999.0181 · Cited by 156
Effects of Omapatrilat in Low, Normal, and High Renin Experimental Hypertension
Trippodo, N. C. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00404-4 · Cited by 156
McClerren, A. L., Endsley, S., Bowman, J. L., Andersen, N. H., Guan, Z., Rudolph, J., & Raetz, C. R. H. (2005) · Biochemistry · doi:10.1021/bi0518186 · Cited by 155
Shaw-Reid, C. A., Munshi, V., Graham, P., Wolfe, A. L., Witmer, M. V., Danzeisen, R. C., Olsen, D. B., Carroll, S. S., Embrey, M. W., Wai, J. S. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200621200 · Cited by 155
Luo, X., Liu, Y., Kubicek, S., Myllyharju, J., Tumber, A., Ng, S. S., Che, K. H., Podoll, J. D., Heightman, T. D., Oppermann, U. C. T., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201597b · Cited by 155
Treatment of Multiple Myeloma: A Comprehensive Review
Kyle, R. A., & Rajkumar, S. V. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.n.056 · Cited by 154
Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis
Sakamoto, H., Mashima, T., Kizaki, A., Dan, S., Hashimoto, Y., Naito, M., & Tsuruo, T. (2000) · Blood · doi:10.1182/blood.v95.10.3214 · Cited by 154
Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1
McKiernan, P. J. (2006) · Drugs · doi:10.2165/00003495-200666060-00002 · Cited by 153
Cole, K. E., Dowling, D. P., Boone, M. A., Phillips, A. J., & Christianson, D. W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205972n · Cited by 153
Recent advances in the discovery of potent and selective HDAC6 inhibitors
Wang, X.-X., Wan, R.-Z., & Liu, Z.-P. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.040 · Cited by 152
New Delhi Metallo-beta-lactamase around the world: An eReview using Google Maps
Berrazeg, M., Diene, S. M., Medjahed, L., Parola, P., Drissi, M., Raoult, D., & Rolain, J. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.20.20809 · Cited by 152
Development of 5-lipoxygenase inhibitors—lessons from cellular enzyme regulation
Werz, O., & Steinhilber, D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.018 · Cited by 151
Serre, L., Sailland, A., Sy, D., Boudec, P., Rolland, A., Pebay‐Peyroula, E., & Cohen‐Addad, C. (1999) · Structure · doi:10.1016/s0969-2126(99)80124-5 · Cited by 151
Klumpp, K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg881 · Cited by 151
Selective Inhibition of Factor Inhibiting Hypoxia-Inducible Factor
McDonough, M. A., McNeill, L. A., Tilliet, M., Papamicaël, C. A., Chen, Q., Banerji, B., Hewitson, K. S., & Schofield, C. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja050841b · Cited by 151
RNase H activity: structure, specificity, and function in reverse transcription
Schultz, S. J., & Champoux, J. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.007 · Cited by 150
Solbiati, J., Chapman‐Smith, A., Miller, J. L., Miller, C. G., & Cronan, J. E. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2913 · Cited by 150
TNP-470: an angiogenesis inhibitor in clinical development for cancer
Kruger, E. A., & Figg, W. D. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.6.1383 · Cited by 150
Szegedi, A., Rujescu, D., Tadić, A., Müller, M., Kohnen, R., Stassen, H. H., & Dahmen, N. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500289 · Cited by 149
Harousseau, J., Martinelli, G., Wiktor-Jędrzejczak, W., Brandwein, J. M., Bordessoule, D., Masszi, T., Ossenkoppele, G. J., Alexeeva, J. A., Beutel, G., Maertens, J. A., et al. (2009) · Blood · doi:10.1182/blood-2009-01-198093 · Cited by 149
Rose, N. R., Woon, E. C. Y., Kingham, G. L., King, O. N. F., Mecinović, J., Clifton, I. J., Ng, S. S., Talib-Hardy, J., Oppermann, U. C. T., McDonough, M. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901680b · Cited by 148
Puerta, D. T., Lewis, J. A., & Cohen, S. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0485513 · Cited by 148
Self-citationProteomics-based Target Identification
Towbin, H., Bair, K. W., DeCaprio, J. A., Eck, M. J., Kim, S., Kinder, F. R. J., Morollo, A. A., Mueller, D. R., Schindler, P. A., Song, H. K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309039200 · Cited by 148
Interaction Between the Renin-Angiotensin-Aldosterone and Sympathetic Nervous Systems
Saxena, P. R. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199219006-00013 · Cited by 147
Billamboz, M., Bailly, F., Lion, C. J., Touati, N., Vezin, H., Calmels, C., Andréola, M., Christ, F., Debyser, Z., & Cotelle, P. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1014692 · Cited by 147
Designing therapeutically effective 5-lipoxygenase inhibitors
McMillan, R. M., & Walker, E. R. H. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90100-k · Cited by 147
Use of a Pharmacophore Model To Discover a New Class of Influenza Endonuclease Inhibitors
Parkes, K. E. B., Ermert, P., Fässler, J., Ives, J. A. L., Martin, J. A., Merrett, J. H., Obrecht, D., Williams, G., & Klumpp, K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020334u · Cited by 147
Lowther, W. T., Orville, A. M., Madden, D. T., Lim, S., Rich, D. H., & Matthews, B. W. (1999) · Biochemistry · doi:10.1021/bi990684r · Cited by 147
Al‐Tawfiq, J. A., Laxminarayan, R., & Mendelson, M. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.11.415 · Cited by 147
Marshall, C. G., Broadhead, G., Leskiw, B. K., & Wright, G. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6480 · Cited by 146
Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal
Distler, M. G., Plant, L. D., Sokoloff, G., Hawk, A. J., Aneas, I., Wuenschell, G. E., Termini, J. S., Meredith, S. C., Nóbrega, M. A., & Palmer, A. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61319 · Cited by 146
Crowley, B. M., & Boger, D. L. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0572912 · Cited by 145
Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors
Bäckström, R., Honkanen, E., Pippuri, A., et al. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00124a017 · Cited by 145
Crystal Structures of Human 108V and 108M Catechol O-Methyltransferase
Rutherford, K., Trong, I. L., Stenkamp, R. E., & Parson, W. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.040 · Cited by 144
Hinchliffe, P., Yang, Q., Portal, E. A. R., Young, T. A., Li, H., Tooke, C. L., Carvalho, M. J., Paterson, N. G., Brem, J., Niumsup, P. R., et al. (2017) · Scientific Reports · doi:10.1038/srep39392 · Cited by 144
Himmel, D. M., Maegley, K. A., Pauly, T., Bauman, J. D., Das, K., Dharia, C., Clark, A. D., Ryan, K., Hickey, M. J., Love, R. A., et al. (2009) · Structure · doi:10.1016/j.str.2009.09.016 · Cited by 143
Zawadzke, L. E., Bugg, T. D. H., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00220a033 · Cited by 142
Development of a histone deacetylase 6 inhibitor and its biological effects
Lee, J.-H., Mahendran, A., Yao, Y., Ngo, L., Venta-Perez, G., Choy, M. L., Kim, N., Ham, W.-S., Breslow, R., & Marks, P. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313893110 · Cited by 141
Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy
Brożyna, A. A., VanMiddlesworth, L., & Slominski, A. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23664 · Cited by 141
Peng, Y., Ueng, S., Tseng, C., Hung, M., Song, J., Wu, J., Liao, F.-Y., Fan, Y.-S., Wu, M.-H., Hsiao, W., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01390 · Cited by 141
Iron center, substrate recognition and mechanism of peptide deformylase
Becker, A., Schlichting, I., Kabsch, W., Groche, D., Schultz, S., & Wagner, A. (1998) · Nature Structural Biology · doi:10.1038/4162 · Cited by 140
Isoxaflutole: the background to its discovery and the basis of its herbicidal properties
Pallett, K. E., Cramp, S. M., Little, J. P., Veerasekaran, P., Crudace, A. J., & Slater, A. E. (2001) · Pest Management Science · Cited by 139
Baggio, R. F., Elbaum, D., Kanyo, Z. F., Carroll, P. J., Cavalli, R. C., Ash, D. E., & Christianson, D. W. (1997) · Journal of the American Chemical Society · doi:10.1021/ja971312d · Cited by 139
The Methionyl Aminopeptidase from Escherichia coli Can Function as an Iron(II) Enzyme
D'souz, V. M., & Holz, R. C. (1999) · Biochemistry · doi:10.1021/bi990872h · Cited by 137
Cathcart, G. R., Quinn, D. J., Greer, B., Harriott, P., Lynas, J. F., Gilmore, B., & Walker, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00776-10 · Cited by 137
Stein, J. H., Congbalay, R. C., Karsh, D. L., Osgood, R. W., & Ferris, T. F. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106972 · Cited by 137
Mullard, A. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.4 · Cited by 137
Howard, L., Maciewicz, R. A., & Blobel, C. (2000) · Biochemical Journal · doi:10.1042/bj3480021 · Cited by 136
Chicoric Acid Analogues as HIV-1 Integrase Inhibitors
Lin, Z., Neamati, N., Zhao, H., Kiryu, Y., Turpin, J. A., Aberham, C., Strebel, K., Kohn, K. W., Witvrouw, M., Pannecouque, C. C., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980531m · Cited by 136
Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor
Min, D., Tang, W., & Mrksich, M. (2004) · Nature Biotechnology · doi:10.1038/nbt973 · Cited by 136
Potent Mechanism-based Inhibitors for Matrix Metalloproteinases
Ikejiri, M., Bernardo, M. M., Bonfil, R. D., Tóth, M., Chang, M., Fridman, R. A., & Mobashery, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504303200 · Cited by 136
Brownlee, J. M., Johnson-Winters, K. L., Harrison, D. H. T., & Moran, G. R. (2004) · Biochemistry · doi:10.1021/bi049317s · Cited by 136
Sweeney, A. M., Lange, R., Fernandes, R. P. M., Schulz, H., Dale, G. E., Douangamath, A., Proteau, P., & Oefner, C. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.10.030 · Cited by 135
Cyclic Boronates Inhibit All Classes of β-Lactamases
Cahill, S. T., Cain, R. M., Wang, D. Y., Lohans, C. T., Wareham, D. W., Oswin, H. P., Mohammed, J., Spencer, J., Fishwick, C. W. G., McDonough, M. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02260-16 · Cited by 135
d-Lactate production in erythrocytes infected with Plasmodium falciparum
Jagt, D. L. V., Hunsaker, L. A., Campos, N. M., & Baack, B. R. (1990) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(90)90171-h · Cited by 134
Spotlight on ixazomib: potential in the treatment of multiple myeloma
Azab, A. K., Muz, B., Ghazarian, R., Ou, M., Luderer, M. J., & Kusdono, H. D. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s93602 · Cited by 134
Rapid Diagnosis of Als/Ahas-Resistant Weeds
Gerwick, B. C., Mireles, L. C., & Eilers, R. J. (1993) · Weed Technology · doi:10.1017/s0890037x00027986 · Cited by 134
Wittmann, M., & Helliwell, P. (2013) · Dermatology and Therapy · doi:10.1007/s13555-013-0023-0 · Cited by 132
New β‐lactam–β‐lactamase inhibitor combinations in clinical development
Shlaes, D. M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12010 · Cited by 130
Thiolutin is a zinc chelator that inhibits the Rpn11 and other JAMM metalloproteases
Lauinger, L., Li, J., Shostak, A., Cemel, I., Ha, N., Zhang, Y., Merkl, P., Obermeyer, S., Stankovic‐Valentin, N., Schafmeier, T., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2370 · Cited by 130
Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates
Slominski, A. T., & Carlson, J. A. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.02.009 · Cited by 129
Recent Advances in the Search for Novel 5‐Lipoxygenase Inhibitors
Steinhilber, D., & Hofmann, B. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12114 · Cited by 129
Hamada, S., Kim, T., Suzuki, T., Itoh, Y., Tsumoto, H., Nakagawa, H., Janknecht, R., & Miyata, N. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.098 · Cited by 128
The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I
Kawatani, M., Okumura, H., Honda, K., Kanoh, N., Muroi, M., Dohmae, N., Takami, M., Kitagawa, M., Futamura, Y., Imoto, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712239105 · Cited by 128
Mullard, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.14 · Cited by 128
Ker�nen, T., Gordin, A., Karlsson, M., et al. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00199880 · Cited by 127
Bacterial Peptide Deformylase Inhibitors: A New Class of Antibacterial Agents
Jain, R., Chen, D., White, R. L., Patel, D., & Yuan, Z. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054367194 · Cited by 127
Sato, S., Kwon, Y., Kamisuki, S., Srivastava, N., Mao, Q., Kawazoe, Y., & Uesugi, M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0655643 · Cited by 127
Brown, A. C., & Parish, T. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-78 · Cited by 126
Reinventing the ACE inhibitors: some old and new implications of ACE inhibition
Hanif, K., Bid, H. K., & Konwar, R. (2009) · Hypertension Research · doi:10.1038/hr.2009.184 · Cited by 126
Reuter, K., Sanderbrand, S., Jomaa, H., Wiesner, J., Steinbrecher, I., Beck, E., Hintz, M., Klebe, G., & Stubbs, M. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109500200 · Cited by 126
Mabry, R., Brasky, K. M., Geiger, R., et al. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00023-06 · Cited by 126
Structure–function relationships of human JmjC oxygenases—demethylases versus hydroxylases
Markolovic, S., Leissing, T. M., Chowdhury, R., Wilkins, S. E., Lü, X., & Schofield, C. J. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.05.013 · Cited by 126
Peptide Deformylase: A New Type of Mononuclear Iron Protein
Rajagopalan, P. T. R., Yu, X. C., & Pei, D. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9734096 · Cited by 125
Eubanks, L. M., Hixon, M. S., Jin, W., Hong, S., Clancy, C. M., Tepp, W. H., Baldwin, M. R., Malizio, C. J., Goodnough, M. C., Barbieri, J. T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611213104 · Cited by 125
Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition
Brem, J., van Berkel, S. S., Aik, W. S., Rydzik, A. M., Avison, M. B., Pettinati, I., Umland, K., Kawamura, A., SPENCER, J. M., Claridge, T. D. W., et al. (2014) · Nature Chemistry · doi:10.1038/nchem.2110 · Cited by 125
Kossel, A., & Dakin, H. D. (1904) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1904.41.4.321 · Cited by 125
Colistin: still a lifesaver for the 21st century?
Karaiskos, I., Souli, M., Galani, I., & Giamarellou, H. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1230200 · Cited by 125
Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase
González, M. M., Kosmopoulou, M. N., Mojica, M. F., Castillo, V., Hinchliffe, P., Pettinati, I., Brem, J., Schofield, C. J., Mahler, G., Bonomo, R. A., et al. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00046 · Cited by 124
Romagni, J. G., Meazza, G., Nanayakkara, N. P. D., & Dayan, F. E. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01907-4 · Cited by 123
Catalytic Properties of Human Liver Alcohol Dehydrogenase Isoenzymes
BOSRON, W. F., & Li, T. (2017) · Enzyme · doi:10.1159/000469238 · Cited by 122
西岡, 謙. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12221.x · Cited by 121
Tramontano, E., Esposito, F., Badas, R., Santo, R. D., Costi, R., & Colla, P. L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2004.11.002 · Cited by 121
Lobell, R. B., Liu, D., Buser, C. A., Davide, J. P., DePuy, E., Hamilton, K., Koblan, K. S., Lee, Y., Mosser, S. D., Motzel, S. L., et al. (2002) · PubMed · Cited by 121
Ünver, N., Freyschmidt‐Paul, P., Horster, S., Wenck, H., Stäb, F., Blatt, T., & Elsässer, H. P. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07210.x · Cited by 121
Structure of the catalytic domain of the colistin resistance enzyme MCR-1
Stojanoski, V., Sankaran, B., Prasad, B. V. V., Poirel, L., Nordmann, P., & Palzkill, T. G. (2016) · BMC Biology · doi:10.1186/s12915-016-0303-0 · Cited by 121
Bronstein-Sitton, N., Cohen‐Daniel, L., Vaknin, I., Ezernitchi, A. V., Leshem, B., Halabi, A., Houri‐Haddad, Y., Greenbaum, E., Zakay‐Rones, Z., Shapira, L., et al. (2003) · Nature Immunology · doi:10.1038/ni975 · Cited by 120
Mullard, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4545 · Cited by 119
NDM‐1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism
Kim, Y., Cunningham, M. A., Mire, J., Tesar, C., Sacchettini, J. C., & Joachimiak, A. (2013) · The FASEB Journal · doi:10.1096/fj.12-224014 · Cited by 119
Wu, Z., Wright, G. D., & Walsh, C. T. (1995) · Biochemistry · doi:10.1021/bi00008a008 · Cited by 118
Eastman, R. T., C, F. S. B. A., Yokoyama, K., Gelb, M. H., & Voorhis, W. C. V. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500016-jlr200 · Cited by 118
Biou, V., Dumas, R., Cohen‐Addad, C., Douce, R., Job, D., & Pebay‐Peyroula, E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3405 · Cited by 118
Hall, D. R., Leonard, G. A., Reed, C. D., Watt, C. I. F., Berry, A., & Hunter, W. N. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2609 · Cited by 117
Vasopeptidase Inhibition: A Double-Edged Sword?
Campbell, D. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000054215.71691.16 · Cited by 116
McCandless, S. E., Yanovski, J. A., Miller, J. E., Fu, C., Bird, L. M., Salehi, P., Chan, C. L., Stafford, D. E. J., Abuzzahab, M. J., Viskochil, D. H., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13021 · Cited by 116
Song, Y., Li, S., Ray, A., Das, D. S., Qi, J., Samur, M., Tai, Y., Munshi, N. C., Carrasco, R. D., Chauhan, D., et al. (2017) · Oncogene · doi:10.1038/onc.2017.172 · Cited by 116
Mullard, A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4239 · Cited by 116
6-Aminoquinolones as New Potential Anti-HIV Agents
Cecchetti, V., Parolin, C., Moro, S., Pecere, T., Filipponi, E., Calistri, A., Tabarrini, O., Gatto, B., Palumbo, M., Fravolini, A., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9903390 · Cited by 116
Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer
Shim, J. S., Matsui, Y., Bhat, S., Nacev, B. A., Xu, J., Bhang, H.-E. C., Dhara, S., Han, K. C., Chong, C. R., Pomper, M. G., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq457 · Cited by 115
Johns, B. A., Weatherhead, J. G., Allen, S. H., Thompson, J. B., Garvey, E. P., Foster, S. A., Jeffrey, J., & Miller, W. H. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.090 · Cited by 114
Loya, S., Tal, R., Kashman, Y., & Hizi, A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.2009 · Cited by 114
The role of histone demethylases in cancer therapy
Hoffmann, I., Roatsch, M., Schmitt, M., Carlino, L., Pippel, M., Sippl, W., & Jung, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.004 · Cited by 114
Liang, Y., Vogel, J. L., Arbuckle, J. H., Rai, G., Jadhav, A., Simeonov, A. M., Maloney, D. J., & Kristie, T. M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005145 · Cited by 113
Boron‐based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center
Freund, Y. R., Akama, T., Alley, M. R. K., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.058 · Cited by 113
Williams, R., Lim, J. E., Harr, B., Wing, C., Walters, R., Distler, M. G., Teschke, M., Wu, C., Wiltshire, T., Su, A. I., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004649 · Cited by 113
Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum
Umeda, T., Tanaka, N., Kusakabe, Y., Nakanishi, M., Kitade, Y., & Nakamura, K. (2011) · Scientific Reports · doi:10.1038/srep00009 · Cited by 113
Screening inhibitors of anthrax lethal factor
Tonello, F., Seveso, M., Marin, O., Mock, M., & Montecucco, C. (2002) · Nature · doi:10.1038/418386a · Cited by 113
The Role of Adams in Notch Signaling
Groot, A. J., & Vooijs, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_2 · Cited by 112
Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase
Cho, H., Ueda, M., Tamaoka, M., HAMAGUCHI, M., Aisaka, K., Kiso, Y., Inoue, T., Ogino, R., & Tatsuoka, T. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00108a039 · Cited by 112
Hydroxamic Acid Derivatives as Potent Peptide Deformylase Inhibitors and Antibacterial Agents
Apfel, C. M., Banner, D. W., Bur, D., Dietz, M., Hirata, T., Hubschwerlen, C., Locher, H. H., Page, M. G. P., Pirson, W., Rossé, G., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000018k · Cited by 112
1-Deoxy-d-xylulose 5-phosphate reductoisomerase: an overview
Proteau, P. (2004) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2004.08.004 · Cited by 112
Tomaras, A. P., McPherson, C. J., Kuhn, M., Carifa, A., Mullins, L. M., George, D. M., Desbonnet, C. R., Eidem, T. M., Montgomery, J. I., Brown, M. F., et al. (2014) · mBio · doi:10.1128/mbio.01551-14 · Cited by 112
Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase
Kuzuhara, T., Iwai, Y., Takahashi, H., Hatakeyama, D., & Echigo, N. (2009) · PLoS Currents · doi:10.1371/currents.rrn1052 · Cited by 111
Long, S. B., Hancock, P. J., Kral, A. M., Hellinga, H. W., & Beese, L. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241407898 · Cited by 111
Borrmann, S., Lundgren, I., Oyakhirome, S., Impouma, B., Matsiegui, P., Adégnika, A. A., Issifou, S., Kun, J. F. J., Hutchinson, D., Wiesner, J., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00392-06 · Cited by 111
Rationally Designed Multitarget Agents Against Inflammation and Pain
Hwang, S. H., Wecksler, A. T., Wagner, K. M., & Hammock, B. D. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320130013 · Cited by 111
Barb, A. W., Jiang, L., Raetz, C. R. H., & Zhou, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709412104 · Cited by 111
Wanty, C., Anandan, A., Piek, S., Walshe, J. L., Ganguly, J., Carlson, R. W., Stubbs, K. A., Kahler, C. M., & Vrielink, A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.06.029 · Cited by 110
IDO inhibitors move center stage in immuno-oncology
Sheridan, C. (2015) · Nature Biotechnology · doi:10.1038/nbt0415-321 · Cited by 110
Lock, E. A., Ellis, M. K., Gaskin, P., Robinson, M., Auton, T. R., Provan, W. M., Smith, L. L., Prisbylla, M. P., Mutter, L. C., & Lee, D. L. (1998) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005458703363 · Cited by 109
Physiologically Relevant Metal Cofactor for Methionine Aminopeptidase-2 Is Manganese
Wang, J., Sheppard, G. S., Lou, P., Kawai, M., Park, C., Egan, D. A., Schneider, A. J., Bouska, J. J., Lesniewski, R., & Henkin, J. (2003) · Biochemistry · doi:10.1021/bi020670c · Cited by 109
Investigating the Selectivity of Metalloenzyme Inhibitors
Day, J. A., & Cohen, S. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401053m · Cited by 109
Self-citationGLO1 —A novel amplified gene in human cancer
Santarius, T., Bignell, G. R., Greenman, C., Widaa, S., Chen, L., Mahoney, C., Butler, A. P., Edkins, S., Waris, S., Thornalley, P. J., et al. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20784 · Cited by 108
Significance of Adenosine Deaminase Activity and Its Isoenzymes in Tuberculous Effusions
Ungerer, J. P. J., Oosthuizen, H. M., Retief, J., & Bissbort, S. (1994) · CHEST Journal · doi:10.1378/chest.106.1.33 · Cited by 108
Pisani, L., Muncipinto, G., Miscioscia, T. F., Nicolotti, O., Leonetti, F., Catto, M., Caccia, C., Salvati, P., Soto‐Otero, R., Méndez‐Álvarez, E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9010127 · Cited by 108
Kamath, S., Kapatral, V., & Chakrabarty, A. M. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01121.x · Cited by 108
Omapatrilat—the story of Overture and Octave
Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00389-3 · Cited by 107
Rausch, J. W., & Le Grice, S. F. J. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.016 · Cited by 106
Fosmidomycin‐Clindamycin forPlasmodium falciparumInfections in African Children
Borrmann, S., Adégnika, A. A., Matsiegui, P., Issifou, S., Schindler, A., Mawili-Mboumba, D. P., Baranek, T., Wiesner, J., Jomaa, H., & Kremsner, P. G. (2004) · The Journal of Infectious Diseases · doi:10.1086/381785 · Cited by 106
Burnett, J. C., Ruthel, G. T., Stegmann, C. M., Panchal, R. G., Nguyen, T. L., Hermone, A. R., Stafford, R. G., Lane, D. J., Kenny, T., McGrath, C. F., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608166200 · Cited by 106
Rådmark, O. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00032-1 · Cited by 106
Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine
Batson, S., de Chiara, C., Majce, V., Lloyd, A. J., Gobec, S., Rea, D., Fülöp, V., Thoroughgood, C. W., Simmons, K. J., Dowson, C. G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02118-7 · Cited by 106
Weber, M. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06584-9 · Cited by 106
Rodríguez-Concepción, M., Campos, N., Lois, L. M., Maldonado, C., Hoeffler, J., Grosdemange‐Billiard, C., Rohmer, M., & Boronat, A. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01552-0 · Cited by 105
Species-Specific and Inhibitor-Dependent Conformations of LpxC: Implications for Antibiotic Design
Lee, C.-J., Liang, X., Chen, X., Zeng, D., Joo, S. H., Chung, H. S., Barb, A. W., Swanson, S. M., Nicholas, R. A., Li, Y., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.11.011 · Cited by 105
Glyoxalase inhibitors as potential anticancer agents
Vince, R., & Wadd, W. B. (1969) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(69)90445-8 · Cited by 104
Summa, V., Petrocchi, A., Matassa, V. G., Gardelli, C., Muraglia, E., Rowley, M., Paz, O. G., Laufer, R., Monteagudo, E. S., & Pace, P. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060854f · Cited by 104
Fuchs, S., Xiao, H., Cole, J. M., Adams, J. W., Frenzel, K. E., Michaud, A., Zhao, H., Keshelava, G., Capecchi, M. R., Corvol, P. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400149200 · Cited by 104
Using ACE inhibitors appropriately.
Bicket, D. P. (2002) · PubMed · Cited by 103
Medicinal Chemistry of CatecholO-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility
Kiss, L. E., & Soares-da-Silva, P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500572b · Cited by 102
Vuorio, R., & Vaara, M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.826 · Cited by 101
Prosser, G. A., & de Carvalho, L. P. S. (2013) · FEBS Journal · doi:10.1111/febs.12108 · Cited by 101
Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections
Brown, M. F., Reilly, U. D., Abramite, J. A., Arcari, J. T., Oliver, R., Barham, R. A., Che, Y., Chen, J. M., Collantes, E. M., Chung, S. W., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2014748 · Cited by 100
Kirschberg, T. A., Balakrishnan, M., Squires, N. H., Barnes, T. L., Brendza, K. M., Chen, X., Eisenberg, E. J., Jin, W., Kutty, N., Leavitt, S. A., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900597q · Cited by 100
Britten, C. D., Rowinsky, E. K., Soignet, S. L., Patnaik, A., Yao, S., Deutsch, P., Lee, Y., Lobell, R. B., Mazina, K. E., McCreery, H., et al. (2001) · PubMed · Cited by 100
Reverse Transcription of Retroviruses and LTR Retrotransposons
Hughes, S. H. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0027-2014 · Cited by 99
Actinonin: an Antibiotic Substance produced by an Actinomycete
Gordon, J. J., KELLY, B. K., & MILLER, G. A. (1962) · Nature · doi:10.1038/195701b0 · Cited by 99
Identification of a Peptoid Inhibitor of the Proteasome 19S Regulatory Particle
Lim, H., Archer, C. T., & Kodadek, T. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072027p · Cited by 99
Merello, M., Lees, A. J., Webster, R. A., Bovingdon, M., & Gordin, A. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.2.186 · Cited by 98
Georgiadis, D., & Yiotakis, A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.058 · Cited by 98
Structure of Peptide Deformylase and Identification of the Substrate Binding Site
Becker, A., Schlichting, I., Kabsch, W., Schultz, S., & Wagner, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11413 · Cited by 98
Yajima, S., Nonaka, T., Kuzuyama, T., Seto, H., & Ohsawa, K. (2002) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003105 · Cited by 98
The spread and acquisition of NDM-1: a multifactorial problem
Wailan, A. M., & Paterson, D. L. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.856756 · Cited by 97
A 1.2-Å snapshot of the final step of bacterial cell wall biosynthesis
Lee, W., McDonough, M. A., Kotra, L. P., Li, Z., Silvaggi, N. R., Takeda, Y., Kelly, J. A., & Mobashery, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1427 · Cited by 97
Enzymology, Structure, and Dynamics of Acetohydroxy Acid Isomeroreductase
Dumas, R., Biou, V., Halgand, F., Douce, R., & Duggleby, R. G. (2001) · Accounts of Chemical Research · doi:10.1021/ar000082w · Cited by 97
5-Lipoxygenase Antagonist therapy: a new approach towards targeted cancer chemotherapy
Bishayee, K., & Khuda‐Bukhsh, A. R. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt064 · Cited by 97
Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension
Rasoul, S., Carretero, O. A., Peng, H., Cavasin, M. A., Zhuo, J. L., Sánchez-Mendoza, A., Brigstock, D. R., & Rhaleb, N. (2004) · Journal of Hypertension · doi:10.1097/00004872-200403000-00023 · Cited by 96
Geurink, P. P., van der Linden, W. A., Mirabella, A., Gallastegui, N., de Bruin, G., Blom, A. E. M., Voges, M. J. E. E. E., Mock, E. D., Florea, B. I., van der MAREL, G. A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3016987 · Cited by 96
Angiotensin converting enzyme inhibitors in hypertension: potential problems
Antonios, T. F., & MacGregor, G. A. (1995) · Journal of Hypertension · doi:10.1097/00004872-199509003-00003 · Cited by 95
A high‐affinity competitive inhibitor of type A botulinum neurotoxin protease activity
Schmidt, J. J., & Stafford, R. G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03738-9 · Cited by 95
Novel Binding Mode of Hydroxamate Inhibitors to Human Carbonic Anhydrase II
Scolnick, L. R., Clements, A. M., Liao, J. C., Crenshaw, L., Hellberg, M. R., May, J. A., Dean, T. R., & Christianson, D. W. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963832z · Cited by 95
Cunliffe, C. J., Franklin, T. J., Hales, N. J., & Hill, G. B. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00092a016 · Cited by 94
The Comparative Effects of Angiotensin and Noradrenaline on Consecutive Vascular Sections
Folkow, B., Johansson, B., & Mellander, S. (1961) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1961.tb02267.x · Cited by 94
Zandt, M. C. V., Whitehouse, D. L., Gołȩbiowski, A., Ji, M. K., Zhang, M., Beckett, R. P., Jagdmann, G. E., Ryder, T. R., Sheeler, R., Andreoli, M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400014c · Cited by 94
Mullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.15 · Cited by 94
Bussiere, D. E., Pratt, S. D., Katz, L., Severin, J. M., Holzman, T. F., & Park, C. H. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80115-x · Cited by 93
Yamaguchi, Y., Jin, W., Matsunaga, K., Ikemizu, S., Yamagata, Y., Wachino, J.-I., Shibata, N., Arakawa, Y., & Kurosaki, H. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701031n · Cited by 93
Suzuki, T., Ozasa, H., Itoh, Y., Zhan, P., Sawada, H., Mino, K., Walport, L. J., Ohkubo, R., Kawamura, A., Yonezawa, M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400624b · Cited by 93
Ceconi, C., Francolini, G., Olivares, A., Comini, L., Bachetti, T., & Ferrari, R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.061 · Cited by 93
Molecular Validation of LpxC as an Antibacterial Drug Target in Pseudomonas aeruginosa
Mdluli, K. E., Witte, P. R., Kline, T. B., Barb, A. W., Erwin, A. L., Mansfield, B. E., McClerren, A. L., Pirrung, M. C., Tumey, L. N., Warrener, P., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00140-06 · Cited by 93
Activation/Attenuation Model for RNase H
Keck, J. L., Goedken, E. R., & Marqusee, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34128 · Cited by 92
Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity
Bénard, C., Zouhiri, F., Normand‐Bayle, M., Danet, M., Desmaële, D., Leh, H., Mouscadet, J. F., Mbemba, G., Thomas, C., Bonnenfant, S., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.005 · Cited by 92
Borkow, G., Fletcher, R. S., Barnard, J. F., Arion, D., Motakis, D., Dmitrienko, G. I., & Parniak, M. A. (1997) · Biochemistry · doi:10.1021/bi9624696 · Cited by 91
Henriksson, L. M., Unge, T., Carlsson, J., Åqvist, J., Mowbray, S. L., & Jones, T. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701935200 · Cited by 91
Cyclic Boronates Inhibit All Classes of β-Lactamase
Cahill, S. T., Cain, R. M., Wang, D. Y., Lohans, C. T., Wareham, D. W., Oswin, H. P., Mohammed, J., SPENCER, J. M., Fishwick, C. W. G., McDonough, M. A., et al. (2017) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 91
Crystal Structure of the Catalytic Domain of Human ADAM33
Orth, P., Reichert, P., Wang, W., Prosise, W. W., Yarosh-Tomaine, T., Hammond, G., Ingram, R. N., Xiao, L., Mirza, U. A., Zou, J., et al. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.037 · Cited by 90
The Importance of Adenosine Deaminase for Lymphocyte Development and Function
Aldrich, M. B., Blackburn, M. R., & Kellems, R. E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2773 · Cited by 90
Apud, J. A., & Weinberger, D. R. (2007) · CNS Drugs · doi:10.2165/00023210-200721070-00002 · Cited by 90
Junot, C., Gonzales, M.-F., Ezan, É., Cotton, J., Vazeux, G., Michaud, A., Azizi, M., Vassiliou, S., Yiotakis, A., Corvol, P. L., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29576-8 · Cited by 90
Retroviral integrase inhibitors year 2000: update and perspectives
Pommier, Y. G., Marchand, C., & Neamati, N. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00112-1 · Cited by 90
Dhiman, R. K., Schaeffer, M. L., Bailey, A. M., Testa, C. A., Scherman, H., & Crick, D. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.24.8395-8402.2005 · Cited by 89
Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease
Waløen, K., Kleppe, R., Martínez, A., & Haavik, J. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1272581 · Cited by 89
Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma
Bruno, F., Spaziano, G., Liparulo, A., Roviezzo, F., Nabavi, S. M., Sureda, A., Filosa, R., & D'Agostino, B. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.020 · Cited by 89
Hypertension management: an update.
Nguyen, Q., Dominguez, J., Nguyen, L. D., & Gullapalli, N. (2010) · Europe PMC (PubMed Central) · Cited by 88
Rabbani, N., Xue, M., Weickert, M. O., & Thornalley, P. J. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.006 · Cited by 88
Mullins, L. S., Zawadzke, L. E., Walsh, C. T., & Raushel, F. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38801-5 · Cited by 87
Schmidt, J. J., Stafford, R. G., & Bostian, K. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01041-2 · Cited by 87
Zürcher, G., Hh, K., Kettler, R., Borgulya, J., Bonetti, E. P., Eigenmann, R., & Prada, M. D. (1990) · PubMed · Cited by 87
Interaction of Retroviral Reverse Transcriptase with Template–Primer Duplexes during Replication
Arts, E. J., & Grice, S. F. J. L. (1997) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60041-0 · Cited by 86
Cenci, S., Oliva, L., Cerruti, F., Milan, E., Bianchi, G., Raule, M., Mezghrani, A., Pasqualetto, E., Sitia, R., & Cascio, P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1011497 · Cited by 86
Trippodo, N. C., Robl, J. A., Asaad, M. M., et al. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12124-1 · Cited by 86
Trader, D. J., Simanski, S., & Kodadek, T. J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b02069 · Cited by 86
Discovery of an Inhibitor of the Proteasome Subunit Rpn11
Perez, C., Li, J., Parlati, F., Rouffet, M., Ma, Y., MacKinnon, A. L., Chou, T., Deshaies, R. J., & Cohen, S. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01379 · Cited by 86
Self-citationCrucial role of CA cleavage sites in the cap‐snatching mechanism for initiating viral mRNA synthesis
Rao, P., Yuan, W., & Krug, R. M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg109 · Cited by 85
Adenosine deaminase inhibitors: Their role in chemotherapy and immunosuppression
Glazer, R. I. (1980) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00255266 · Cited by 85
Cox, J. D., Cama, E., Colleluori, D. M., Pèthe, S., Boucher, J., Mansuy, D., Ash, D. E., & Christianson, D. W. (2001) · Biochemistry · doi:10.1021/bi002318+ · Cited by 85
Wang, H., Liu, Y., Chen, Y., Robinson, H. H., & Ke, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504398200 · Cited by 85
Histone Deacetylase Inhibitors: Latest Developments, Trends and Prospects
Moradei, O. M., Maroun, C. R., Paquin, I., & Vaisburg, A. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011054866946 · Cited by 84
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
Jin, S.-L. C., Lin, S., & Ding, S.-L. (2012) · Biomedical Journal · doi:10.4103/2319-4170.106152 · Cited by 84
Cited by
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Yang, B., Chen, Y., & Shi, J. (2019) · Advanced Materials · doi:10.1002/adma.201901778 · Cited by 601
Cong, Y., Yang, S., & Rao, X. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2019.10.005 · Cited by 527
Chaudhary, D., Chong, F., Neupane, T., Choi, J., & Jee, J.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413661 · Cited by 14
Metadata
- Authors
- Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-09-07
- Volume
- 119
- Issue
- 2
- Pages
- 1323-1455
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2889619860
- Cited by
- 270
- References
- 925
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.